Only on January 12, 13, and 14, 2026 — enjoy 10% off all Peptides products!
Two products — one conscious approach
Zhenoluten and Mamiton are capsule-based complexes for women, developed with consideration of hormonal, immune, andage-related characteristics.
Subscribe to mailing and get the latest news and discounts of our store.>
- News
- About our products
- About store
- Delivery
- Payment
- How to buy
- Contacts
- Privacy policy
- Terms & Conditions
Please note our office schedule during the holiday period as Latvia prepares to celebrate its Independence Day on November 18.
Peptides announces the release of the updated and expanded 2025 edition of the guidebook «Complex Application of Peptides Products» specially adapted for practical use across the European market.
Wishing you good health, sunny spirits, and a wonderful holiday surrounded by your loved ones! Please note our online store’s holiday schedule:
The year 2025 became an anniversary year for us — Peptides celebrated its 15th anniversary! We are sincerely grateful to everyone who has been with us throughout these years.
We have come a long and eventful journey full of growth and achievements, made possible through your commitment, professionalism, and genuine trust in the values we share.
We are pleased to announce you important news: in the near future an updated preparation will appear in the assortment — Calcium Complex, which will replace the well-known Calsil-T.
We are always delighted to share new informational products with you. We present methodological guidelines developed by Peptides Company experts: "Enhancing the Reserve Capacity of the Body in Fitness Club Members and Athletes Using Peptide and Non-Peptide Bioregulators"
May your holidays be warm, bright, and truly magical!
Office schedule during the holidays:
We inform you that since August 1, 2025, Gelmigon, with batch No. 0624, has been withdrawn from sale
Kidney diseases are a global health challenge, affecting 10-20% of the population and significantly impacting quality of life. Therefore, our new research article in the SIC project focuses on the use of peptide bioregulators (such as Pielotax, Ovagen, and Renefort) in the prevention and treatment of kidney pathologies.
























